投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量48.28% (2022年為43.09%)
自引率
2.0 %
年文章數(shù)
1975
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):14895)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):5337次)
作者需知
暫無(wú)數(shù)據(jù)
NCBI查詢
偏重的研究方向
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
Official Organ of the "German Working Group for Gene Therapy (DAG-GT)" Official Organ of the "Biomedical Research Association (KBF)" The employment of molecular biology and gene technology has enhanced the understanding of human diseases creating a new branch of research - that of "molecular medicine". The Journal of Molecular Medicine (JMM) publishes original papers rapid communications review articles and correspondence of the highest quality pertinent to all aspects of human biology and pathophysiology. The application of research involving gene technology gene therapy molecular structural analysis genetic epidemiology and molecular and clinical pharmacology has made unprecedented progress and precision possible in the understanding prevention diagnosis and treatment of human diseases. These areas of molecular medicine therefore will be given particular attention by the editorial board. Papers describing in vitro or animal studies will be accepted if they are relevant to normal or pathological human biology. Please include at the end of the acknowledgements a declaration that the experiments comply with the current laws of the country in which the experiments were performed.
常用鏈接
期刊論壇
|
中國(guó)SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
